海军医学杂志
海軍醫學雜誌
해군의학잡지
JOURNAL OF NAVY MEDICINE
2014年
4期
288-290
,共3页
蒙果%李鸣皋%韩磊%杨业兵%赵鑫
矇果%李鳴皋%韓磊%楊業兵%趙鑫
몽과%리명고%한뢰%양업병%조흠
奥美沙坦酯%原发性高血压%血压%心率变异性
奧美沙坦酯%原髮性高血壓%血壓%心率變異性
오미사탄지%원발성고혈압%혈압%심솔변이성
Olmesartan%Primary hypertension%Blood pressure%Heart rate variability
目的:探讨奥美沙坦酯对原发性高血压患者血压和心率变异性的影响。方法选择原发性高血压患者46例作为治疗组,给予奥美沙坦酯治疗,另选同期健康体检者40例作为对照组,比较治疗组治疗前后心率变异性指标( SDNN、SDANN、RMSSD、PNN50、LF、HF、LF/HF)的变化及降压效果,并与对照组比较。结果治疗组治疗前SDNN、SDANN、RMSSD、PNN50均低于对照组,治疗后各项指标均较治疗前升高(P<0.01),但仍低于对照组(P<0.05)。治疗组治疗后收缩压、舒张压、心率均低于治疗前,差异有统计学意义( P<0.05);与对照组比较差异无统计学意义( P>0.05)。结论原发性高血压患者应用奥美沙坦酯可显著降低血压,并能够显著改善患者心率变异性。
目的:探討奧美沙坦酯對原髮性高血壓患者血壓和心率變異性的影響。方法選擇原髮性高血壓患者46例作為治療組,給予奧美沙坦酯治療,另選同期健康體檢者40例作為對照組,比較治療組治療前後心率變異性指標( SDNN、SDANN、RMSSD、PNN50、LF、HF、LF/HF)的變化及降壓效果,併與對照組比較。結果治療組治療前SDNN、SDANN、RMSSD、PNN50均低于對照組,治療後各項指標均較治療前升高(P<0.01),但仍低于對照組(P<0.05)。治療組治療後收縮壓、舒張壓、心率均低于治療前,差異有統計學意義( P<0.05);與對照組比較差異無統計學意義( P>0.05)。結論原髮性高血壓患者應用奧美沙坦酯可顯著降低血壓,併能夠顯著改善患者心率變異性。
목적:탐토오미사탄지대원발성고혈압환자혈압화심솔변이성적영향。방법선택원발성고혈압환자46례작위치료조,급여오미사탄지치료,령선동기건강체검자40례작위대조조,비교치료조치료전후심솔변이성지표( SDNN、SDANN、RMSSD、PNN50、LF、HF、LF/HF)적변화급강압효과,병여대조조비교。결과치료조치료전SDNN、SDANN、RMSSD、PNN50균저우대조조,치료후각항지표균교치료전승고(P<0.01),단잉저우대조조(P<0.05)。치료조치료후수축압、서장압、심솔균저우치료전,차이유통계학의의( P<0.05);여대조조비교차이무통계학의의( P>0.05)。결론원발성고혈압환자응용오미사탄지가현저강저혈압,병능구현저개선환자심솔변이성。
Objective To investigate the effect of olmesartan on blood pressure and heart rate variability in patients with pri -mary hypertension .Methods Forty-six patients with primary hypertension were selected as the treatment group , which was given olme-sartan.Another 40 health examinees at the same period were chosen as the control group .The effect of olmesartan on heart rate variabil-ity(SDNN, SDANN, RMSSD, PNN50)and effect on the reduction of blood pressure were compared both before and after treatment , and comparisons were made with those of the control group .Results Before medication , the indicators of SDNN , SDANN, RMSSD and PNN50 for the treatment group were all lower than those of the control group .However, after medication, those indicators were elevated than those before medication, but was still lower than those of the control group , with statistical significance (P<0.05).After treat-ment , systolic blood pressure , diastolic blood pressure and heart rate were all lower than those before treatment , also with statistical sig-nificance (P<0.05).No statistical significance could be seen, when comparisons were made with those of the control group (P>0.05).Conclusion The application of olmesartan in patients with primary hypertension could not only significantly decrease blood pressure, but improve patient heart rate variability .